MedTrace Logo

A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure

NCT02135835 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 365

Last updated 2018-03-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Shenfu Zhusheye in patients with acute heart failure.

Conditions

  • Acute Heart Failure

Interventions

DRUG

Shenfu Zhusheye

DRUG

5% glucose injection

Sponsors & Collaborators

  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jiefu Yang · Beijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-03
Primary Completion
2017-03-24
Completion
2017-03-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135835 on ClinicalTrials.gov